NCT Number: NCT00032721
The Use of Reiki for Patients With Advanced AIDS
This study will investigate the use of Reiki, an energy-based complementary and alternative medicine (CAM) intervention, as an approach to improve well-being for patients with advanced AIDS, and evaluate its effects on dimensions of well-being and quality of life.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States
About this study
This study will investigate the use of Reiki, an energy-based complementary and alternative medicine (CAM) intervention, as an approach to improve well being for patients with advanced AIDS, and evaluate its effects on dimensions of well being and quality of life. The study is a two-group comparison between participants receiving Reiki plus usual medical care (treatment) and participants receiving usual medical care only (control).
One hundred and forty-six patients with advanced AIDS will be enrolled and randomized into the two groups. Patients in the intervention (Reiki) group will receive a total of three one-hour Reiki sessions over a period of 6 weeks. Participants in both the intervention and control groups will be assessed at two times during the study period using repeated measures. We will investigate and compare changes in participants' anxiety, depression, pain, quality of life, and spiritual well being at the end of the intervention period. This is the first part of a longer-term research agenda to examine the use and effectiveness of complementary and alternative medicines for patients with advanced disease. We plan to examine one clinical context in which Reiki is currently provided. It is important to design studies that respect both the context of care and the practitioner-client relationship-elements essential to an understanding of the philosophy and delivery of CAM such as Reiki, and at the same time endeavor to outline a systematic approach to the study of CAM.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis of advanced AIDS, defined as: CD4 count of less than 200 during the past 12 months;
- On HAART for at least 6 months;
- Over age 18;
- Decisionally capable of providing informed consent.
Exclusion criteria
- Not capable of providing informed consent because of psychiatric limitations, e.g. active psychosis.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Nih
Registry information
Important dates
- Study start
- 2002
- Study completion
- 2003
- First posted
- Apr 1, 2002
- Registry last updated
- Aug 18, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
NCT04772469
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Siaya, Kenya
View Trial DetailsVicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
NCT00474370
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
View Trial DetailsErythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection
NCT00000587
Acquired Immunodeficiency Syndrome, Anemia
View Trial DetailsSafety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
NCT01705574
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Los Angeles, California, United States
View Trial Details